Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
F Yıldız
Observed names:
F. Yıldız,
Fatih Yildiz,
Fatih Yıldız
Institutions:
Ankara Onkoloji Eğitim ve Araştırma Hastanesi,
Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital
Observed institutions:
Ankara Onkoloji Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi,
Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital
ORCID:
0000-0003-2295-7332
Observed ORCID:
0000-0003-2295-7332
OpenAlex ID:
A5109726019
Predicting survival after brain metastases in patients with bladder cancer
2024
·
T. Önder
, C. Karaçin
, et al.
·
Journal of Clinical Neuroscience
·
6
Bevacizumab combined with irinotecan or temozolomide in recurrent glioblastoma: a Turkish Oncology Group (TOG) study
2026
·
Sinem Akbas
, Ozkan Alan
, et al.
·
Journal of Neuro-Oncology
·
1
Evaluation of the Prognostic Importance of Gustave Roussy Immune Score in Hepatocellular Cancer Etiological Subtypes
2025
·
İlknur Deliktaş Onur
, Hatice Gülgün Fırat
, et al.
·
Turkish Journal of Clinics and Laboratory
PDF
Show more works
View as search
Works count:
3
Citation count:
7
H-index:
1
I10-index:
Year
Topic
Type